Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy

Overexpression of the human epidermal growth factor receptor 2 (HER2) defines a subgroup of breast tumors with aggressive behavior. The addition of HER2-targeted antibodies (i.e., trastuzumab, pertuzumab) to chemotherapy significantly improves relapse-free and overall survival in patients with early...

Descripción completa

Detalles Bibliográficos
Autores principales: Muntasell, Aura, Cabo, Mariona, Servitja, Sonia, Tusquets, Ignasi, Martínez-García, María, Rovira, Ana, Rojo, Federico, Albanell, Joan, López-Botet, Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694168/
https://www.ncbi.nlm.nih.gov/pubmed/29181007
http://dx.doi.org/10.3389/fimmu.2017.01544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694168/
https://www.ncbi.nlm.nih.gov/pubmed/29181007
http://dx.doi.org/10.3389/fimmu.2017.01544

Ejemplares similares